Jiadi Hu

发表

Synergistic Suppression of Prostatic Cancer Cells by Coexpression of Both Murine Double Minute 2 Small Interfering RNA and Wild-Type p53 Gene In Vitro and In Vivo

Xin Li, L. Cai, Xue-jian Zhao, 2011, Journal of Pharmacology and Experimental Therapeutics.

Viral G protein-coupled receptor up-regulates Angiopoietin-like 4 promoting angiogenesis and vascular permeability in Kaposi's sarcoma

A. Molinolo, A. Sodhi, J. Basile, 2010, Proceedings of the National Academy of Sciences.

Angiopoietin-like 4: a novel molecular hallmark in oral Kaposi's sarcoma.

John M. Wright, J. Basile, John Wright, 2011, Oral oncology.

Amplification of the Angiogenic Signal through the Activation of the TSC/mTOR/HIF Axis by the KSHV vGPCR in Kaposi's Sarcoma

P. Pandolfi, A. Schneider, A. Sodhi, 2011, PloS one.

Delivery of the co-expression plasmid pEndo-Si-Stat3 by attenuated Salmonella serovar typhimurium for prostate cancer treatment

D. Kalvakolanu, D. Kopecko, Xue-jian Zhao, 2013, Journal of Cancer Research and Clinical Oncology.

Synergistic Suppression of Melanoma Growth by a Combination of Natural dsRNA and Panaxadiolsaponins.

D. Kalvakolanu, Yanying Zhao, Xue-jian Zhao, 2018, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Characterization of monoclonal antibodies against GRIM-19, a novel IFN-beta and retinoic acid-activated regulator of cell death.

J. Choe, J. Hayashi, T. Seo, 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Dual inhibition of PI3Kalpha and mTOR as an alternative treatment for Kaposi's sarcoma.

K. Shokat, Z. Knight, B. Jham, 2008, Cancer research.

Dual Inhibition of PI 3 K A and mTOR as an Alternative Treatment for Kaposi ’ s Sarcoma

K. Shokat, Z. Knight, B. Jham, 2008 .

The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma.

J. Gutkind, A. Sodhi, S. Montaner, 2006, Cancer research.

Dual Inhibition of PI3K A and mTOR as an Alternative Treatment for Kaposi’s Sarcoma

K. Shokat, Z. Knight, B. Jham, 2008 .

Treatment for Kaposi's Sarcoma and mTOR as an Alternative α Dual Inhibition of PI3K

K. Shokat, Z. Knight, B. Jham, 2008 .

The cell death regulator GRIM-19 is an inhibitor of signal transducer and activator of transcription 3

S. Roy, G. Stark, V. Poli, 2003, Proceedings of the National Academy of Sciences of the United States of America.

The TSC2/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor.

E. Sausville, B. Manning, J. Gutkind, 2006, Cancer cell.

Inositol hexakisphosphate kinase 2 sensitizes ovarian carcinoma cells to multiple cancer therapeutics

Mamta Chawla-Sarkar, B. Gong, D. Kalvakolanu, 2002, Oncogene.

Tumor-suppressive activity of the cell death activator GRIM-19 on a constitutively active signal transducer and activator of transcription 3.

S. Reddy, D. Kalvakolanu, D. Lindner, 2007, Cancer research.

Intratumoral delivery and suppression of prostate tumor growth by attenuated Salmonella enterica serovar typhimurium carrying plasmid-based small interfering RNAs.

D. Kalvakolanu, D. Kopecko, Xue-jian Zhao, 2007, Cancer research.

Down-Regulation of Signal Transducer and Activator of Transcription 3 Expression Using Vector-Based Small Interfering RNAs Suppresses Growth of Human Prostate Tumor In vivo

D. Kalvakolanu, D. Kopecko, Xue-jian Zhao, 2005, Clinical Cancer Research.

Effects of Plasmid-Based Stat3-Specific Short Hairpin RNA and GRIM-19 on PC-3M Tumor Cell Growth

D. Kalvakolanu, D. Kopecko, Xue-jian Zhao, 2008, Clinical Cancer Research.

Thioredoxin reductase plays a critical role in IFN retinoid-mediated tumor-growth control in vivo.

D. Kalvakolanu, D. Lindner, Xinrong Ma, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Modulation of p53 dependent gene expression and cell death through thioredoxin-thioredoxin reductase by the Interferon-Retinoid combination

S. Reddy, D. Kalvakolanu, D. Lindner, 2001, Oncogene.

Regulation of Interferon and Retinoic Acid-induced Cell Death Activation through Thioredoxin Reductase*

S. Reddy, D. Kalvakolanu, D. Lindner, 2001, The Journal of Biological Chemistry.

A Novel Transactivating Factor That Regulates Interferon-γ-dependent Gene Expression*

K. Hashimoto, S. Roy, Junbo Hu, 2002, The Journal of Biological Chemistry.

Development of monoclonal antibodies against GBF1 and their use in studying its functions.

S. Roy, S. Reddy, Junbo Hu, 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Hypoxic retinal Müller cells promote vascular permeability by HIF-1–dependent up-regulation of angiopoietin-like 4

G. Semenza, E. Duh, J. Handa, 2013, Proceedings of the National Academy of Sciences.

Plasmid-based E6-specific siRNA and co-expression of wild-type p53 suppresses the growth of cervical cancer in vitro and in vivo.

D. Kalvakolanu, D. Kopecko, Lijing Zhao, 2013, Cancer letters.

Antitumor effects of Stat3-siRNA and endostatin combined therapies, delivered by attenuated Salmonella, on orthotopically implanted hepatocarcinoma

D. Kopecko, Xue-jian Zhao, Baofeng Guo, 2012, Cancer Immunology, Immunotherapy.

Upregulation of angiopoietin-like 4 by viral G protein-coupled receptor promotes angiogenesis and vascular permeability in Kaposi’s sarcoma

A. Sodhi, J. Basile, B. Jham, 2010, Infectious Agents and Cancer.

Effects of Plasmid-Based Stat3-Specific Short Hairpin RNA and GRIM-19 on PC-3M Tumor Cell Growth

D. Kalvakolanu, D. Kopecko, Xue-jian Zhao, 2008, Clinical Cancer Research.